Per Åkesson
1 – 10 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Aerosolized Dornase Alfa (DNase I) for the Treatment of Severe Respiratory Failure in COVID-19 : A Randomized Controlled Trial
- Contribution to journal › Article
- 2020
-
Mark
Scores for sepsis detection and risk stratification – construction of a novel score using a statistical approach and validation of RETTS
- Contribution to journal › Article
-
Mark
Risk of bacteremia in patients presenting with shaking chills and vomiting - A prospective cohort study
- Contribution to journal › Article
-
Mark
Improved Outcomes After Regional Implementation of Sepsis Alert : A Novel Triage Model
- Contribution to journal › Article
-
Mark
Accelerated treatment of endocarditis—The POET II trial : Rationale and design of a randomized controlled trial: Design and rationale of the POET II trial
- Contribution to journal › Article
-
Mark
The authors reply
- Contribution to journal › Letter
-
Mark
Musculoskeletal infection in orthopaedic trauma : Assessment of the 2018 international consensus meeting on musculoskeletal infection
- Contribution to journal › Article
-
Mark
Repeated measures of Heparin-binding protein (HBP) and procalcitonin during septic shock : biomarker kinetics and association with cardiovascular organ dysfunction
- Contribution to journal › Article
- 2019
-
Mark
Multidisciplinärt endokarditteam på plats i Skåne - Första årets erfarenhet visar riktningen framåt
- Contribution to journal › Article
-
Mark
Heparin-Binding Protein As A Prognostic Biomarker of Sepsis and Disease Severity at The Emergency Department
- Contribution to journal › Article
